IngentaConnect Search Results

Bisphosphonates in the Prevention of Disease Recurrence: Current Results and Ongoing Trials

Author: Gnant, M.

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 824-833(10)

Publisher: Bentham Science Publishers

Authors: Zografos, G. N.; Georgiadou, D.; Thomas, D.; Kaltsas, G.; Digalakis, M.

Source: Diseases of the Esophagus, Volume 22, Number 8, November 2009 , pp. 633-637(5)

Cost-Effectiveness of Using Clinical Risk Factors with and without DXA for Osteoporosis Screening in Postmenopausal Women

Authors: Mueller, Dirk; Gandjour, Afschin

Source: Value in Health, Volume 12, Number 8, November/December 2009 , pp. 1106-1117(12)

Publisher: Blackwell Publishing

Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases

Authors: Boonen, S.; Kay, R.; Cooper, C.; Haentjens, P.; Vanderschueren, D.; Callewaert, F.; Milisen, K.; Ferrari, S.

Source: International Journal of Clinical Practice, Volume 63, Number 12, December 2009 , pp. 1792-1804(13)

Publisher: Blackwell Publishing

Antiepileptic drugs increase fracture risk in postmenopausal women

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 2-2(1)

Publisher: Adis International

Lapatinib plus letrozole for postmenopausal patients with advanced HER2⁺/HR⁺ breast cancer

Author: Guarneri, Valentina

Source: Expert Review of Anticancer Therapy, Volume 9, Number 11, November 2009 , pp. 1549-1557(9)

Publisher: Expert Reviews

A cohort study of the effects of serum osteoprotegerin and osteoprotegerin gene polymorphisms on cardiovascular mortality in elderly women

Authors: Ueland, Thor; Wilson, Scott G.; Amirul Islam, F. M.; Mullin, Ben; Devine, Amanda; Bollerslev, Jens; Zhu, Kun; Prince, Richard L.

Source: Clinical Endocrinology, Volume 71, Number 6, December 2009 , pp. 828-833(6)

Publisher: Blackwell Publishing

Challenges in defining predictive markers for response to endocrine therapy in breast cancer

Authors: Larionov, Alexey A; Miller, William R

Source: Future Oncology, Volume 5, Number 9, November 2009 , pp. 1415-1428(14)

Publisher: Future Medicine

Pelvic floor function is independently associated with pelvic organ prolapse

Authors: Brækken, IH; Majida, M; Ellström Engh, M; Holme, IM; Bø, K

Source: BJOG: An International Journal of Obstetrics & Gynaecology, Volume 116, Number 13, December 2009 , pp. 1706-1714(9)

Publisher: Blackwell Publishing

Oestradiol Protects Against the Harmful Effects of Fluoride More by Increasing Thiol Group Levels than Scavenging Hydroxyl Radicals

Authors: Dlugosz, Anna; Roszkowska, Anna; Zimmer, Mariusz

Source: Basic & Clinical Pharmacology & Toxicology, Volume 105, Number 6, December 2009 , pp. 366-373(8)

Publisher: Blackwell Publishing

Risedronic-acid: more cost effective with wider application

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 12-12(1)

Publisher: Adis International

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

Authors: Rabaglio, M.; Sun, Z.; Price, K. N.; Castiglione-Gertsch, M.; Hawle, H.; Thrlimann, B.; Mouridsen, H.; Campone, M.; Forbes, J. F.; Paridaens, R. J.; Colleoni, M.; Pienkowski, T.; Nogaret, J.-M.; Lng, I.; Smith, I.; Gelber, R. D.; Goldhirsch, A.; Coates, A. S.

Source: Annals of Oncology, Volume 20, Number 9, 24 September 2009 , pp. 1489-1498(10)

Publisher: Oxford University Press

Women's experiences with vaginal pessary use

Authors: Storey, Sandra; Aston, Megan; Price, Sheri; Irving, Linda; Hemmens, Erin

Source: Journal of Advanced Nursing, Volume 65, Number 11, November 2009 , pp. 2350-2357(8)

Publisher: Blackwell Publishing

Predictors of response to exemestane as primary endocrine therapy in estrogen receptor-positive breast cancer

Authors: Yamashita, Hiroko; Takahashi, Satoru; Ito, Yukashi; Yamashita, Toshinari; Ando, Yoshiaki; Toyama, Tatsuya; Sugiura, Hiroshi; Yoshimoto, Nobuyasu; Kobayashi, Shunzo; Fujii, Yoshitaka; Iwase, Hirotaka

Source: Cancer Science, Volume 100, Number 11, November 2009 , pp. 2028-2033(6)

Publisher: Blackwell Publishing

Undertreatment of menopausal symptoms and novel options for comprehensive management

Author: Lewis, Vivian

Source: Current Medical Research and Opinion, Volume 25, Number 11, November 2009 , pp. 2689-2698(10)

Publisher: Informa Healthcare

Vitamin D repletion does not alter urinary calcium excretion in healthy postmenopausal women

Authors: Penniston, Kristina L.; Jones, Andrea N.; Nakada, Stephen Y.; Hansen, Karen E.

Source: BJU International, Volume 104, Number 10, November 2009 , pp. 1512-1516(5)

Publisher: Blackwell Publishing

Comment on Kanis et al.: “European guidance for the diagnosis and management of osteoporosis in postmenopausal women”

Author: Clausen, J.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1631-1631(1)

Publisher: Springer

Monthly ibandronate suppresses serum CTX-I within 3 days and maintains a monthly fluctuating pattern of suppression

Authors: Binkley, N.; Silverman, S.; Simonelli, C.; Santiago, N.; Kohles, J.; Dasic, G.; Sunyecz, J.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1595-1601(7)

Publisher: Springer

Greater osteoporosis educational outreach is desirable among Chinese immigrants in Chinatown, Chicago

Authors: Tan, S.; Ji, L.; Tsai, J.; Eng, J.; Ko, H.-J.; Yau, A.; Edwards, G.; Bunta, A.; Edwards, B.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1517-1522(6)

Publisher: Springer

Spinal deformity index (SDI) is a good predictor of incident vertebral fractures

Authors: Kerkeni, S.; Kolta, S.; Fechtenbaum, J.; Roux, C.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1547-1552(6)

Publisher: Springer